{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:44:13Z","timestamp":1732041853387},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,12,1]]},"DOI":"10.2169\/internalmedicine.0404-22","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T22:13:21Z","timestamp":1663020801000},"page":"3605-3609","source":"Crossref","is-referenced-by-count":4,"title":["Anti-signal Recognition Particle Antibody-positive Immune-mediated Myopathy after mRNA-1273 SARS-CoV-2 Vaccination"],"prefix":"10.2169","volume":"61","author":[{"given":"Masanobu","family":"Tanemoto","sequence":"first","affiliation":[{"name":"Department of Neurology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Kosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Toyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Kosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Shizukawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Kosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Yokokawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syuuichirou","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Hisahara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. World Health Organization. WHO coronavirus (COVID-19) dashboard [Internet]. [cited 2022 May 25]. Available from: https:\/\/covid19.who.int"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Klein NP, Lewis N, Goddard K, et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA 326: 1390-1399, 2021.","DOI":"10.1001\/jama.2021.15072"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Anquetil C, Boyer O, Wesner N, Benveniste O, Allenbach Y. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy. Autoimmun Rev 18: 223-230, 2019.","DOI":"10.1016\/j.autrev.2018.09.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bergua C, Chiavelli H, Allenbach Y, et al. <i>In vivo<\/i> pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotizing myopathy. Ann Rheum Dis 78: 131-139, 2019.","DOI":"10.1136\/annrheumdis-2018-213518"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Benveniste O, Drouot L, Jouen F, et al. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum 63: 1961-1971, 2011.","DOI":"10.1002\/art.30344"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dodig D, Fritzler MJ, Naraghi A, Tarnopolsky MA, Lu JQ. Immune-mediated necrotizing myopathy after BNT162b2 vaccination in a patient with antibodies against receptor-binding domain of SARS-CoV-2 and signal recognition particle. Muscle Nerve 65: 11-13, 2022.","DOI":"10.1002\/mus.27483"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tan CY, Toh TH, Toh YF, Wong KT, Shahrizaila N, Goh KJ. A temporal association between COVID-19 vaccination and immune-mediated necrotizing myopathy. Muscle Nerve 65: E24-E26, 2022.","DOI":"10.1002\/mus.27531"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Blaise M, Rocher F, Spittler H, et al. Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanoma. J Eur Acad Dermatol Venereol 36: e100-e102, 2022.","DOI":"10.1111\/jdv.17760"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. St\u00fcbgen JP. A review on the association between inflammatory myopathies and vaccination. Autoimmun Rev 13: 31-39, 2014.","DOI":"10.1016\/j.autrev.2013.08.005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Patone M, Handunnetthi L, Saatci D, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med 27: 2144-2153, 2021.","DOI":"10.1038\/s41591-021-01556-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mamarabadi M, Baisre A, Leitch M, Hsu V, Kanduri JS, Chen S. Case of anti-single recognition particle-mediated necrotizing myopathy after influenza vaccination. J Clin Neuromuscul Dis 19: 211-216, 2018.","DOI":"10.1097\/CND.0000000000000208"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Oberli MA, Reichmuth AM, Dorkin JR, et al. Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy. Nano Lett 17: 1326-1335, 2017.","DOI":"10.1021\/acs.nanolett.6b03329"},{"key":"13","unstructured":"13. Anderson EJ, Rouphael NG, Widge AT, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 383: 2427-2438, 2020."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Au L, Fendler A, Shepherd STC, et al. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2. Nat Med 27: 1362-1366, 2021.","DOI":"10.1038\/s41591-021-01387-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ohnuki Y, Suzuki S, Shiina T, et al. HLA-DRB1 alleles in immune-mediated necrotizing myopathy. Neurology 87: 1954-1955, 2016.","DOI":"10.1212\/WNL.0000000000003160"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/23\/61_0404-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:31:26Z","timestamp":1670038286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/23\/61_0404-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":15,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0404-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"0404-22"}}